Stock listing

Promis Neurosciences Inc.

Selected listing: A41MFQ · LS · EUR · DE

Promis Neurosciences Inc. (Lang & Schwarz: A41MFQ), Health Technology. Latest release Oct 6, 2026: ProMIS Neurosciences Appoints Seasoned Alzheimer’s…

A41MFQ:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A41MFQ
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Promis Neurosciences Inc.

ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer

October 5, 2026

ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer

October 5, 2026

ProMIS Neurosciences to Participate in Upcoming Conferences and Events in September

September 1, 2026

ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights

August 13, 2026

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

August 3, 2026

All Promis Neurosciences Inc. news →

Research Promis Neurosciences Inc.

Promis Neurosciences Inc. company profile

View the public company page for Promis Neurosciences Inc. on 6ix.

Promis Neurosciences Inc. news

Read company news and market updates connected to Promis Neurosciences Inc..

Promis Neurosciences Inc. investor events

Find investor webinars, events, and replay context for Promis Neurosciences Inc..